Inipharm - Crunchbase Company Profile & Funding

Q: Where is Inipharm's headquarters?

Inipharm is located in Seattle, Washington, United States.

Q: Who invested in Inipharm?

Inipharm has 4 investors including Wu Capital And 5AM Ventures.

Q: When was the last funding round for Inipharm?

Inipharm closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Inipharm raised to date?

Inipharm has raised obfuscated.

Overview

Inipharm

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Inipharm

CB Rank

35793

Inipharm is a biopharmaceutical company.

Founded

obfuscation

Private

Series A

Seattle, Washington, United States

1-10

inipharm.com/

Biotechnology

Health Care

Pharmaceutical

Funding Rounds

Series A

OBF

obfuscation

Key People

Brian Farmer: Co-Founder & CEO
Past Role: Laguna Pharmaceuticals, Chief Business Officer
Chuhan Chung: Chief Medical Officer

Details

Legal Name

Inipharm, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Brian Farmer, Michael Gallatin

About the Company

Inipharm is a biopharmaceutical company focused on discovering and developing therapies for severe liver diseases.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

Inipharm Biopharmaceutical Pipeline

A portfolio of drug candidates focused on treating liver and metabolic diseases through novel mechanisms.

Research & Development

Inipharm is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Inipharm	4	obfuscated obfuscation	5AM Ventures, Wu Capital	Series A
obfuscated obfuscation	Series A - Inipharm	4	obfuscated obfuscation	5AM Ventures, Wu Capital	Series A
obfuscated obfuscation	Series A - Inipharm	4	obfuscated obfuscation	5AM Ventures, Wu Capital	Series A
obfuscated obfuscation	Series A - Inipharm	4	obfuscated obfuscation	5AM Ventures, Wu Capital	Series A
obfuscated obfuscation	Series A - Inipharm	4	obfuscated obfuscation	5AM Ventures, Wu Capital	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Inipharm	4	obfuscated obfuscation	5AM Ventures, Wu Capital	Series A
obfuscated obfuscation	Series A - Inipharm	4	obfuscated obfuscation	5AM Ventures, Wu Capital	Series A
obfuscated obfuscation	Series A - Inipharm	4	obfuscated obfuscation	5AM Ventures, Wu Capital	Series A
obfuscated obfuscation	Series A - Inipharm	4	obfuscated obfuscation	5AM Ventures, Wu Capital	Series A
obfuscated obfuscation	Series A - Inipharm	4	obfuscated obfuscation	5AM Ventures, Wu Capital	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Wu Capital	Yes	Series A - Inipharm	Hannah Chang
Wu Capital	Yes	Series A - Inipharm	Hannah Chang
Wu Capital	Yes	Series A - Inipharm	Hannah Chang
Wu Capital	Yes	Series A - Inipharm	Hannah Chang
Wu Capital	Yes	Series A - Inipharm	Hannah Chang